Cytosine methyltransferases as tumor markers

Area of Science:

• Oncology
• Epigenetics
• Molecular Biology

Background:

• Aberrant DNA methylation is a hallmark of human cancers.
• Tumor cells exhibit global hypomethylation and promoter-specific CpG island hypermethylation.
• DNA methyltransferases (DNMTs) catalyze DNA methylation.

Purpose of the Study:

• To review the role of DNA methylation and DNMTs in carcinogenesis.
• To describe chromatin modifying proteins interacting with DNMTs.
• To address DNMTs as potential therapeutic targets in cancer.

Main Methods:

• Literature review of DNA methylation and DNMTs in cancer.
• Analysis of interactions between DNMTs and chromatin modifiers.
• Discussion of therapeutic strategies targeting DNMTs.

Main Results:

• DNA methylation patterns are significantly altered in tumors.
• DNMTs play a critical role in the development of cancer.
• Interactions with chromatin modifiers are crucial for DNMT function.
• DNMTs represent promising targets for cancer therapy.

Conclusions:

• DNA methylation and DNMTs are central to cancer development.
• Targeting DNMTs offers a potential therapeutic avenue for cancer treatment.